This week in Nature: Exercise effects - Mapping the molecular changes induced by endurance

Browse the full issue: nature.com/nature/volumes…

🚨Don’t miss our practical approach to address and optimize cardiorenal therapies and related comorbidities in chronic cardiorenal disease beyond congestion! This is a proposal prepared by Síndrome CardioRenal y Congestión en IC @ICyFA-SEMI S.E.N. Nefrología 💪🏻 🧵 1/9

while waiting for first guidelines (AHA/ACC & ESC expected 2024-25) on myocarditis management, we publish 'Consensus Document for Diagnosis and Treatment of Myocarditis and Inflammatory Cardiomyopathy' on behalf of working group of Soc Esp Cardiología sciencedirect.com/science/articl…

Diagnóstico y tratamiento de la miocarditis y la miocardiopatía inflamatoria: Documento de consenso SEC-GT de miocarditis. Camino hacia protocolizar la y mejorar su manejo sciencedirect.com/science/articl…
Luis Ruiz Guerrero
Fernando Domínguez
Jara Gayan Ordas
Manuel Barreiro-Perez
Pablo Pastor
Domingo Pascual-Figal

Our Paper Just Published on JACC Journals

Prevalence of Pathogenic Variants
in Cardiomyopathy-Associated Genes in Acute Myocarditis

authors.elsevier.com/a/1issb7tD%7EZ…

Athanasios Bakalakos Giuseppe Limongelli Douglas Cannie

Get ready for a new episode of #ESCCardioTalk ! 🌟

In this episode, join Perry Elliott and Athanasios Bakalakos as they discuss 'Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy.'

Tune in now for the…

Cardiac conduction disorders in young adults: clinical characteristics and genetic background of an underestimated population #OpenAccess
cristina balla
heartrhythmjournal.com/article/S1547-…

In GUIDE-IT, repeated #NTproBNP measurements were a strong predictor of outcomes in #HFrEF . These results may support routine NT-proBNP monitoring to guide clinical decision making. bit.ly/3vkU9hu

#JACCHF Michael Fuery MD Tariq Ahmad MD MPH James Januzzi Jr MD

🚨The 2024 ACC Expert Consensus Decision Pathway for HFrEF just landed.

This is truly a 'living document', updated with new information for clinicians and patients.

Thanks to the Writing Committee and @ACCintouch for their commitment to this work.

jacc.org/doi/10.1016/j.…

#Perspective : Myocarditis has evolved from a rare cause of heart failure to a common cause of nonischemic chest pain modified by genes and fibroblast activity. #AHAJournals Mayo Clinic CV @MayoClinic ahajournals.org/doi/10.1161/CI…

𝘍𝘓𝘕𝘊: LA IMPORTANCIA DE LA COLABORACIÓN CLÍNICA-LABORATORIO Y LAS GUÍAS ACMG🧬🩺🏥

La semana pasada recibimos una consulta📩que resultó ser una historia interesante, con mucho aprendizaje. Se trataba de un caso muy antiguo...
[abro hilo👇👇👇]

📰Check out our latest paper about RRAGD, a new gene to consider in DCM with AD inheritance🧬 Circulation: Genomic and Precision Medicine Hospital Universitari Bellvitge | HUB

Let me tell you a story about 2 patients we identified via a research study, both with a rare variant in the cardiac troponin T gene, TNNT2; NM_001001430.3: c.571-1G>A. Both had cardiac phenotypes and both had Oceanian ancestry /1

Nuevos datos del Registro de Amiloidosis Cardiaca de Galicia (AMIGAL) recién publicados en REC. Orgullo galego!
⁦EDUARDO BARGE⁩ ⁦Manuel Lopez Perez⁩ ⁦@INESGOMEZ71⁩ ⁦Marisa Crespo Leiro⁩ ⁦Alberto Bouzas-Mosquera⁩ ⁦Javier Garcia Seara⁩ sciencedirect.com/science/articl…

ICYMI: Radiomics and late gadolinium enhancement (LGE) in #WhyCMR – new quantitative frontier? In this proof of concept study, myocardial LGE radiomics has incremental value in hypertrophic cardiomyopathy sudden death risk prediction. bit.ly/3vnpeAJ

#JACCIMG #cvHCM

Difficult to analyze ATTRibute-CM
nejm.org/doi/full/10.10…

Multiple changing endpoints. Hmm.

Win-ratio is fine, but why not give the actual numbers of events?

Benefit mostly driven by biomarkers -- no diff in death

They don’t tell us total hospitalizations. What…

Tratamiento antitrombótico para procedimientos intervencionistas en Cardiología. Revisión @JACC State-of-the-Art jacc.org/doi/10.1016/j.…

📃📌Our paper “Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers” is available online jmg.bmj.com/content/early/… Here a brief thread of the main findings:

Rate and Cause of Sudden Cardiac Death in the Young During the COVID-19 Pandemic and Vaccination | Circulation ahajournals.org/doi/10.1161/CI…